Stem Cell Transplant With Melphalan Still Preferred in Myeloma – Medscape
Medscape |
Stem Cell Transplant With Melphalan Still Preferred in Myeloma
Medscape Stem cell transplantation with melphalan is still the preferred treatment for younger patients with multiple myeloma, even in the era of new therapies for the disease, according to a phase 3 trial. The results were published in the September 4 issue of … Chemotherapy and stem–cell transplant for multiple myeloma remain superior New Drug Helps Myeloma Patients Who Can't Tolerate Transplant New Myeloma Treatment Options Show Promise |
